Anticoagulation-free VV ECMO for Acute Respiratory Failure

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
Currently international experts recommend therapeutic anticoagulation for veno-venous extracorporeal membrane oxygenation (VV-ECMO). Reports and case series suggest that the absence of therapeutic anticoagulation is safe for VV-ECMO. No randomized control trials have assessed this. The aim of this pilot study is to assess safety and feasibility of an \"anticoagulation-free strategy\" for veno-venous ECMO (VV-ECMO) in Acute respiratory distress syndrome (ARDS).
Epistemonikos ID: 55bf509c59b05e72ac01238cfdfedbb13638c09b
First added on: May 07, 2024